Literature DB >> 30714720

Structural and Functional Studies of Bacterial Enolase, a Potential Target against Gram-Negative Pathogens.

Jolanta Krucinska1, Eric Falcone1, Heidi Erlandsen2, Akram Hazeen3, Michael N Lombardo1, Alexavier Estrada1, Victoria L Robinson4, Amy C Anderson1, Dennis L Wright1,3.   

Abstract

Enolase is a glycolytic metalloenzyme involved in carbon metabolism. The advantage of targeting enolase lies in its essentiality in many biological processes such as cell wall formation and RNA turnover and as a plasminogen receptor. We initially used a DARTS assay to identify enolase as a target in Escherichia coli. The antibacterial activities of α-, β-, and γ-substituted seven-member ring tropolones were first evaluated against four strains representing a range of Gram-negative bacteria. We observed that the chemical properties and position of the substituents on the tropolone ring play an important role in the biological activity of the investigated compounds. Both α- and β-substituted phenyl derivatives of tropolone were the most active with minimum inhibitory concentrations in the range of 11-14 μg/mL. The potential inhibitory activity of the synthetic tropolones was further evaluated using an enolase inhibition assay, X-ray crystallography, and molecular docking simulations. The catalytic activity of enolase was effectively inhibited by both the naturally occurring β-thujaplicin and the α- and β-substituted phenyl derivatives of tropolones with IC50 values in range of 8-11 μM. Ligand binding parameters were assessed by isothermal titration calorimetry and differential scanning calorimetry techniques and agreed with the in vitro data. Our studies validate the antibacterial potential of tropolones with careful consideration of the position and character of chelating moieties for stronger interaction with metal ions and residues in the enolase active site.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30714720      PMCID: PMC6511404          DOI: 10.1021/acs.biochem.8b01298

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  Multifunctional alpha-enolase: its role in diseases.

Authors:  V Pancholi
Journal:  Cell Mol Life Sci       Date:  2001-06       Impact factor: 9.261

2.  Probing chelation motifs in HIV integrase inhibitors.

Authors:  Arpita Agrawal; Jamie DeSoto; Jessica L Fullagar; Kasthuraiah Maddali; Shahrzad Rostami; Douglas D Richman; Yves Pommier; Seth M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-27       Impact factor: 11.205

3.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.

Authors:  Edward Harder; Wolfgang Damm; Jon Maple; Chuanjie Wu; Mark Reboul; Jin Yu Xiang; Lingle Wang; Dmitry Lupyan; Markus K Dahlgren; Jennifer L Knight; Joseph W Kaus; David S Cerutti; Goran Krilov; William L Jorgensen; Robert Abel; Richard A Friesner
Journal:  J Chem Theory Comput       Date:  2015-12-01       Impact factor: 6.006

4.  Synthetic α-Hydroxytropolones as Inhibitors of HIV Reverse Transcriptase Ribonuclease H Activity.

Authors:  Ryan P Murelli; Michael P D'Erasmo; Danielle R Hirsch; Christine Meck; Takashi Masaoka; Jennifer A Wilson; Baofeng Zhang; Rajat K Pal; Emilio Gallicchio; John A Beutler; Stuart F J Le Grice
Journal:  Medchemcomm       Date:  2016-07-07       Impact factor: 3.597

5.  RNaseE and the other constituents of the RNA degradosome are components of the bacterial cytoskeleton.

Authors:  Aziz Taghbalout; Lawrence Rothfield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

6.  Drug affinity responsive target stability (DARTS) for small-molecule target identification.

Authors:  Melody Y Pai; Brett Lomenick; Heejun Hwang; Robert Schiestl; William McBride; Joseph A Loo; Jing Huang
Journal:  Methods Mol Biol       Date:  2015

7.  Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase.

Authors:  Jessica L Fullagar; Amanda L Garner; Anjali K Struss; Joshua A Day; David P Martin; Jing Yu; Xiaoqing Cai; Kim D Janda; Seth M Cohen
Journal:  Chem Commun (Camb)       Date:  2013-03-12       Impact factor: 6.222

8.  The mechanism of the bactericidal activity of hinokitiol.

Authors:  Yasuhiro Morita; Yoshikazu Sakagami; Toshihiro Okabe; Tatsuhiko Ohe; Yoshihiko Inamori; Nakao Ishida
Journal:  Biocontrol Sci       Date:  2007-09       Impact factor: 0.982

9.  Antibacterial activity of selected tropones and tropolones.

Authors:  N A Saleh; A Zwiefak; M Mordarski; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-11

10.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  5 in total

1.  Chlamydia trachomatis RsbU Phosphatase Activity Is Inhibited by the Enolase Product, Phosphoenolpyruvate.

Authors:  Christopher Rosario; Ming Tan
Journal:  J Bacteriol       Date:  2022-09-19       Impact factor: 3.476

2.  Functional and structural basis of E. coli enolase inhibition by SF2312: a mimic of the carbanion intermediate.

Authors:  Jolanta Krucinska; Michael N Lombardo; Heidi Erlandsen; Akram Hazeen; Searle S Duay; Jason G Pattis; Victoria L Robinson; Eric R May; Dennis L Wright
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

3.  An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

Authors:  Yu-Hsi Lin; Nikunj Satani; Naima Hammoudi; Victoria C Yan; Yasaman Barekatain; Sunada Khadka; Jeffrey J Ackroyd; Dimitra K Georgiou; Cong-Dat Pham; Kenisha Arthur; David Maxwell; Zhenghong Peng; Paul G Leonard; Barbara Czako; Federica Pisaneschi; Pijus Mandal; Yuting Sun; Rafal Zielinski; Susana Castro Pando; Xiaobo Wang; Theresa Tran; Quanyu Xu; Qi Wu; Yongying Jiang; Zhijun Kang; John M Asara; Waldemar Priebe; William Bornmann; Joseph R Marszalek; Ronald A DePinho; Florian L Muller
Journal:  Nat Metab       Date:  2020-11-23

4.  Proteomic Analyses of Acinetobacter baumannii Clinical Isolates to Identify Drug Resistant Mechanism.

Authors:  Ping Wang; Ren-Qing Li; Lei Wang; Wen-Tao Yang; Qing-Hua Zou; Di Xiao
Journal:  Front Cell Infect Microbiol       Date:  2021-02-24       Impact factor: 5.293

Review 5.  Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment.

Authors:  Gan Qiao; Anguo Wu; Xiaoliang Chen; Ye Tian; Xiukun Lin
Journal:  Int J Biol Sci       Date:  2021-09-21       Impact factor: 6.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.